- Home
- VNET vs AQST Comparison
VNET vs AQST Comparison
Compare VNET & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNET
- AQST
- Stock Information
- Founded
- VNET 1999
- AQST 2004
- Country
- VNET China
- AQST United States
- Employees
- VNET N/A
- AQST N/A
- Industry
- VNET Computer Software: Programming Data Processing
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- VNET Technology
- AQST Health Care
- Exchange
- VNET Nasdaq
- AQST Nasdaq
- Market Cap
- VNET 531.1M
- AQST 502.6M
- IPO Year
- VNET 2011
- AQST 2018
- Fundamental
- Price
- VNET $3.84
- AQST $5.08
- Analyst Decision
- VNET Strong Buy
- AQST Strong Buy
- Analyst Count
- VNET 3
- AQST 7
- Target Price
- VNET $4.60
- AQST $9.43
- AVG Volume (30 Days)
- VNET 1.6M
- AQST 1.5M
- Earning Date
- VNET 11-20-2024
- AQST 11-04-2024
- Dividend Yield
- VNET N/A
- AQST N/A
- EPS Growth
- VNET N/A
- AQST N/A
- EPS
- VNET N/A
- AQST N/A
- Revenue
- VNET $1,056,473,872.00
- AQST $58,900,000.00
- Revenue This Year
- VNET $9.69
- AQST $16.97
- Revenue Next Year
- VNET $12.53
- AQST N/A
- P/E Ratio
- VNET N/A
- AQST N/A
- Revenue Growth
- VNET 4.85
- AQST 22.56
- 52 Week Low
- VNET $1.39
- AQST $1.55
- 52 Week High
- VNET $4.50
- AQST $6.23
- Technical
- Relative Strength Index (RSI)
- VNET 56.33
- AQST 49.36
- Support Level
- VNET $3.25
- AQST $4.62
- Resistance Level
- VNET $3.68
- AQST $5.80
- Average True Range (ATR)
- VNET 0.25
- AQST 0.34
- MACD
- VNET -0.01
- AQST -0.06
- Stochastic Oscillator
- VNET 98.33
- AQST 38.98
About VNET VNET Group Inc.
VNET started as AsiaCloud in 1999 and moved to the data center business with its first self-developed data center opening in 2010. The firm listed (as 21Vianet) on the Nasdaq in April 2011, subsequently changing its name to VNET Group in 2021. It originally focused on providing data center services such as colocation and cloud services to retail clients in China, but added hyperscale customers in 2019 and now counts large Chinese hyperscalers such as Alibaba Cloud, Tencent Cloud, and Huawei Cloud as customers. At the end of March 2024, it had 48,503 self-built retail cabinets with the majority in Beijing, Shanghai, and the Greater Bay area. It also had 332 MW of wholesale capacity in service with a further 139 MW under construction and a further 557 MW held for future development.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.